From the Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Beijing, People's Republic of China.
Received for publication July 26, 2023; revision accepted August 16, 2023.
Conflicts of interest and sources of funding: The authors declare no conflict of interest. This work was supported by National High Level Hospital Clinical Research Funding (grant 2022-PUMCH-B-071).
Correspondence to: Hongli Jing, MD, PhD, Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, 1 Shuaifuyuan, Dongcheng District, Beijing 100730, People's Republic of China. E-mail: [email protected].
Comments (0)